EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

EZH2 Inhibition by DS3201 Triggers the Kaposi’s Sarcoma-Associated Herpesvirus Lytic Cycle and Potentiates the Effects Induced by SAHA in Primary Effusion Lymphoma Cells

Roberta Gonnella iD, Flavia Collura, Vincenzo Corrado, Michele Di Crosta, Roberta Santarelli iD, Mara Cirone iD

Viruses · 2024

DOI: 10.3390/v16091490 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Roberta Gonnella und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy. Hauptthemen laut MEDLINE: Herpesvirus 8, Human, Lymphoma, Primary Effusion, Enhancer of Zeste Homolog 2 Protein, Histone Deacetylase Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Associazione italiana per la ricerca sul cancro, AIRC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary Effusion Lymphoma (PEL) cells carry Kaposi’s sarcoma-associated herpesvirus (KSHV) in a latent state, except for a small number of cells in which the virus replicates to ensure its persistence into the infected host. However, the lytic cycle can be reactivated in vitro by exposing these lymphoma cells to various treatments, leading to cell lysis. To restrict viral antigen expression, KSHV induces repressive epigenetic changes, including DNA methylation and histone modifications. Among the latter, histone deacetylation and tri-methylation of Histone H3 lisyne-27 (H3K27me3) have been reported to play a role. Here, we found that the inhibition of H3K27 tri-methylation by valemetostat DS3201 (DS), a small molecule that inhibits Enhancer of Zeste Homolog 2 (EZH2) methyltransferase, induced the KSHV lytic cycle in PEL cells, and that this effect involved the activation of the wtp53–p21 axis and autophagic dysregulation. DS also potentiated the lytic cycle activation mediated by the Histone deacetylases (HDAC) inhibitor Suberoylanilide hydroxamic acid (SAHA) and reinforced its cytotoxic effect, suggesting that such a combination could be used to unbalance the latent/lytic cycle and further impair the survival of PEL cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 8, HumanLymphoma, Primary EffusionEnhancer of Zeste Homolog 2 ProteinHistone Deacetylase InhibitorsVorinostatHumansCell Line, TumorVirus LatencyVirus ActivationVirus ReplicationAutophagyHistones

Stichwörter der Autor:innen

KSHVPEL cellsautophagylytic cyclep53

Substanzen

Enhancer of Zeste Homolog 2 ProteinHistone Deacetylase InhibitorsEZH2 protein, humanVorinostatHistones

Autor:innen und Institutionen

  • Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy.

ORCID-Profile: Roberta Gonnella, Roberta Santarelli, Mara Cirone

Förderung

  • Associazione italiana per la ricerca sul cancro
  • AIRC

Zitieren

APA

Gonnella, R., Collura, F., Corrado, V., Di Crosta, M., Santarelli, R., & Cirone, M. (2024). EZH2 Inhibition by DS3201 Triggers the Kaposi’s Sarcoma-Associated Herpesvirus Lytic Cycle and Potentiates the Effects Induced by SAHA in Primary Effusion Lymphoma Cells. Viruses. https://doi.org/10.3390/v16091490

Vancouver

Gonnella R, Collura F, Corrado V, Di Crosta M, Santarelli R, Cirone M. EZH2 Inhibition by DS3201 Triggers the Kaposi’s Sarcoma-Associated Herpesvirus Lytic Cycle and Potentiates the Effects Induced by SAHA in Primary Effusion Lymphoma Cells. Viruses. 2024. doi:10.3390/v16091490

BibTeX
@article{Gonnella2024,
  author = {Gonnella, Roberta and Collura, Flavia and Corrado, Vincenzo and Di Crosta, Michele and Santarelli, Roberta and Cirone, Mara},
  title = {EZH2 Inhibition by DS3201 Triggers the Kaposi’s Sarcoma-Associated Herpesvirus Lytic Cycle and Potentiates the Effects Induced by SAHA in Primary Effusion Lymphoma Cells},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16091490}
}
Kostenlos starten →